Insulin-like growth factor-I regulates the neonatal immune response in infection and maturation by suppression of IFN-γ

Cytokine

Volumn 60, Issue 2, 2012, Pages 369-376

  Puzik, Alexander ^a,b   Rupp, Jan ^b   Tröger, Birte ^b   Göpel, Wolfgang ^b   Herting, Egbert ^b   Härtel, Christoph ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Insulin like growth factor I; Interferon; Interleukin; Neonate; NF B

Indexed keywords

CD14 ANTIGEN; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 6; PROTEIN P50; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; SYNAPTOTAGMIN I; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; BLOOD CULTURE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; MALE; MONOCYTE; MONONUCLEAR CELL; NEWBORN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN SECRETION; TH1 CELL; UMBILICAL CORD BLOOD;

ANTIGENS, CD28; ANTIGENS, CD3; APOPTOSIS; DNA; DOWN-REGULATION; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FEMALE; HUMANS; IMMUNITY; INFANT, NEWBORN; INFECTION; INSULIN-LIKE GROWTH FACTOR I; INTERFERON-GAMMA; INTRACELLULAR SPACE; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MALE; MONOCYTES; NF-KAPPA B; PROTEIN BINDING; RECEPTOR, IGF TYPE 1; TIME FACTORS; TRANSCRIPTION FACTOR AP-1;

EID: 84866749515     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2012.07.025     Document Type: Article

References (44)

1. Chellakooty M., Juul A., Boisen K.A., et al. A prospective study of serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 in 942 healthy infants: associations with birth weight, gender, growth velocity, and breastfeeding. JCEM 2006, 91(3):820-826.
2. Xu S., Gu X., Pan H., et al. Reference ranges for serum IGF-I and IGFBP-3 levels in chinese children during childhood and adolescence. Endocrinol J 2010, 57(3):221-228.
3. LeRoith D., Yanowski J., Kaldjian E.P., et al. The effects of growth hormone and insulin-like growth factor I on the immune system of aged female monkeys. Endocrinology 1996, 137(3):1071-1079.
4. Gluckman P.D., Guan J., Williams C., et al. Asphyxial brain injury - the role of the IGF system. Mol Cell Endocrinol 1998, 140(1-2):95-99.
5. Capoluongo E., Vento G., Ameglio F., et al. Increased levels of IGF-1 and beta2-microglobulin in epithelial lining fluid of preterm newborns developing chronic lung disease effects of rhG-CSF. Int J Immunopathol Pharmacol 2006, 19(1):57-66.
6. Dinleyici E.C., Tekin N., Colak O., Aksit M.A. Cord blood IGF-I and IGFBP-3 levels in asphyxiated term newborns. Neuro Endocrinol Lett 2006, 27(6):745-747.
7. Oswiecimska J.M., Stojewska M., Behrendt J., et al. Effect of intrauterine infection and perinatal risk factors on serum concentrations of insulin like growth factor (IGF-I) in full-term and preterm newborns. Neuro Endocrinol Lett 2008, 29(2):222-229.
8. Berner R., Niemeyer C.M., Leititis J.U., et al. Plasma levels and gene expression of granulocyte colony-stimulating factor, tumor necrosis factor-alpha, interleukin (IL)-1beta, IL-6, IL-8, and soluble intercellular adhesion molecule-1 in neonatal early onset sepsis. Pediatr Res 1998, 44(4):469-477.
9. Schultz C., Rott C., Temming P., Schlenke P., Möller J.C., Bucsky P. Enhanced interleukin-6 and interleukin-8 synthesis in term and preterm infants. Pediatr Res 2002, 51(3):317-322.
10. Leviton A., Dammann O. Coagulation, inflammation, and the risk of neonatal white matter damager. Pediatr Res 2004, 55:541-544.
11. Schultz C., Schultz C., Temming P., Bucsky P., Göpel W., Strunk T., et al. Immature anti-inflammatory response in neonates. Clin Exp Immunol 2003, 135(1):130-136.
12. Tu W., Zhang D.K., Cheung P.T., Tsao S.W., Lau Y.L. Effect of insulin-like growth factor 1 on PHA-stimulated cord blood mononuclear cell telomerase activity. Br J Haematol 1999, 104(4):785-794.
13. Kooijman R., Coppens A. Insulin-like growth factor-I stimulates IL-10 production in human T cells. J Leuk Biol 2004, 76(4):862-867.
14. Law H.K.W., Tu W., Liu E., Lau Y.L. Insulin-like grwoth factor I promotes cord blood T cell maturation through monocytes and inhibits their apoptosis in part through interleukin-6. BMC Immunol 2008, 9(74).
15. Robbins K., McCabe S., Scheiner T., et al. Immunological effects of insulin-like growth factor-I - enhancement of immunoglobulin synthesis. Clin Exp Immunol 1994, 95(2):337-342.
16. Clark R. The somatogenic hormones and insulin-like growth factor-1: stimulators of lymphopoiesis and immune function. Endocr Rev 1997, 18(2):157-179.
17. Tu W., Cheung P.T., Lau Y.L. Insulin-like growth factor 1 promotes cord blood T cell maturation and inhibits its spontaneous and phytohemagglutinin-induced apoptosis through different mechanisms. J Immunol 2000, 165:1331-1336.
18. Kincade P.W., Medina K.L., Smithson G., Scott D.C. Pregnancy: a clue to normal regulation of B lymphopoiesis. Immunol Today 1994, 15(11):539-544.
19. Valentinis B., Baserga R. IGF-I receptor signalling in transformation and differentiation. J Clin Pathol: Mol Pathol 2001, 54:133-137.
20. Samani A.A., Yakar S., LeRoith D., Brodt P. The role of the IGF system in cancer growth and metastasis: overview and recent insights. Endocr Rev 2007, 28(1):20-47.
21. Kooijman R., Lauf J.J., Kappers A.C., Rijkers G.T. Insulin-like growth factor induces phosphorylation of immunoreactive insulin receptor substrate and its association with phosphatidylinositol-3 kinase in human thymocytes. J Exp Med 1995, 182:593-597.
22. Schillaci R., Brocardo M.G., Galeano A., Roldán A. Downregulation of insulin-like growth factor-1 receptor (IGF-1R) expression in human T lymphocytes activation. Cell Immunol 1998, 182(2):157-161.
23. Walsh P.T., O'Connor R. The insulin-like growth factor-I receptor is regulated by CD28 and protects activated T cells from apoptosis. Eur J Immunol 2000, 30(4):1010-1018.
24. Segretin M.E., Galeano A., Roldán A., Schillaci R. Insulin-like growth factor-1 receptor regulation in activated human T lymphocytes. Horm Res 2003, 59(6):276-280.
25. Splawski J.B., Lipsky P. Cytokine regulation of immunglobulin secretion by neonatal lymphocytes. J Clin Invest 1991, 88:967-977.
26. Johnson E.W., Jones L.A., Kozak R.W. Expression and function of insulin-like growth factor receptors on anti-CD3-activated human T lymphocytes. J Immunol 1992, 148(1):63-71.
27. Low L.C., Tam S.Y., Kwan E.Y., Tsang A.M., Karlberg J. Onset of significant GH dependence of serum IGF-I and IGF-binding protein 3 concentrations in early life. Pediatr Res 2001, 50(6):737-742.
28. Kurtoglu S., Aatabek M.E., Gunes T., Akcakus M., Keskin M., Kocaoglu C. Relationship between cord blood levels of IGF-I and ferritin in healthy term neonates. J Pediatr Endocrinol Metab 2004, 17(5):737-742.
29. Ashare A., Nymon A.B., Doerschug K.C., Morrison J.M., Monick M.M., Hunninghake G.W. Insulin-like growth factor-1 improves survival in sepsis via enhanced hepatic bacterial clearance. Am J Respir Crit Care Med 2008, 178(2):149-157.
30. Yang Y., Niu J., Guo L. The effects of antisense insulin-like growth factor-I receptor oligonucleotide on human cord blood lymphocytes. J Mol Endocrinol 2002, 28(3):207-212.
31. Alexandrides T.K., Smith R.J. A novel fetal insulin-like growth factor (IGF) I receptor. Mechanism for increased IGF I- and insulin-stimulated tyrosine kinase activity in fetal muscle. J Biol Chem 1989, 264(22):12922-12930.
32. Alexandrides T.K., Chen J.H., Bueno R., Giorgino F., Smith R.J. Evidence for two insulin-like growth factor I receptors with distinct primary structure that are differentially expressed during development. Regul Pept 1993, 48(1-2):279-290.
33. Abuzzahab M.J., Schneider A., Goddard A., et al. IGF-I receptor mutations resulting in intrauterine and postnatal growth retardation. N Engl J Med 2003, 349(23):2211-2222.
34. Nitsche A., Zhang M., Clauss T., Siegert W., Brune K., Pahl A. Cytokine profiles of cord and adult blood leukocytes: differences in expression are due to differences in expression and activation of transcription factors. BMC Immunol 2007, 8(18).
35. Kern J.A., R.J.Daniele R.P., Nowell P.C. The role of the accessory cell in mitogen-stimulated human T cell gene expression. J Immunol 1986, 137(3):764-769.
36. De Groote D., Zangerlea P.F., Gevaertb Y., et al. Direct stimulation of cytokines (IL-1beta, TNF-alpha, IL-6, IL-2, IFN-gamma and GM-CSF) in whole blood. I. comparison with isolated PBMC stimulation. Cytokine 1992, 4(3):239-248.
37. Freebern V.J., Haggerty C.M., Montano I., et al. Pharmacologic profiling of transcriptional targets deciphers promoter logic. Pharmacogenomics J 2005, 5(5):305-323.
38. Chetty A., Andersson S., Lassus P., Nielsen H.C. Insulin-like growth factor-1 (IGF-1) and IGF-1 receptor (IGF-1R) expression in human lung in RDS and BPD. Pediatr Pulmonol 2004, 37(2):128-136.
39. Cohen L., Haziot A., Shen D.R., et al. CD14-independent responses to LPS require a serum factor that is absent from neonates. J Immunol 1995, 155(11):5337-5342.
40. Kollmann T.R., Crabtree J., Rein-Weston A., et al. Neonatal innate TLRmediated responses are distinct from those of adults. J Immunol 2009, 183(11):7150-7160.
41. Tu W., Cheung P.T., Lau Y.L. IGF-I increases interferon-gamma and IL-6 mRNA expression and protein production in neonatal mononuclear cells. Pediatr Res 1999, 46(6):748-754.
42. Baltimore R.S. Neonatal sepsis: epidemiology and management. Paediatr Drugs 2003, 5(11):723-740.
43. Watson R.S., Carcillo J.A., Linde-Zwirble W.T., Clermont G., Lidicker J., Angus D.C. The epidemiology of severe sepsis in children in the United States. Am J Respir Crit Care Med 2003, 167(5):695-701.
44. Voigt M., Fusch C., Olbertz D., et al. Analysis of the neonatal collective of the federal republic of Germany 12th report: presentation of detailed percentiles for the body measurement of newborns. Geburtsh Frauenheilk 2006, 66(10):956-970.